文献速递组学、生物样本库与精准医学医学人工智能与信息学流行病学与生物统计

基于磁共振成像的多器官时钟用于健康衰老与疾病评估

MRI-based multi-organ clocks for healthy aging and disease assessment.
PubMed 文献 · Nat Med · 2025-10-16

研究基于MULTI联盟313,645人数据构建脑、心、肝、脂肪、脾、肾、胰七个磁共振成像多器官生物学年龄差(MRIBAG),关联2,923种血浆蛋白、327种代谢物和6,477,810个常见遗传变异,并发现53对MRIBAG-基因座关联(P < 5 × 10-8)。

要点

  • 基于313,645人构建七个器官MRIBAG,并关联多组学与疾病终点。
  • 全基因组关联识别53对MRIBAG-基因座关联(P < 5 × 10-8)。
  • 七个MRIBAG与未来系统性疾病终点及全因死亡风险相关。

核心结论

  • 研究开发了七个MRIBAG,扩展了现有多器官生物学衰老框架,并展示其推进衰老研究的临床潜力。

研究设计与样本

  • 研究利用MULTI联盟整理的313,645名个体数据,开发脑、心、肝、脂肪组织、脾、肾和胰腺七个磁共振成像多器官生物学年龄差(MRIBAG)。

主要发现

  • 七个MRIBAG与2,923种血浆蛋白、327种代谢物和6,477,810个常见遗传变异相关联。
  • 全基因组关联分析识别出53对MRIBAG-基因座关联(P < 5 × 10-8)。
  • 遗传相关和孟德尔随机化分析支持器官特异性和跨器官互联,涉及24个非MRI生物学衰老时钟和525个疾病终点。
  • 通过功能基因定位和贝叶斯共定位多组学证据,优先筛选出九个可成药基因作为未来抗衰老治疗靶点。
  • 七个MRIBAG与未来系统性疾病终点(例如糖尿病)和全因死亡风险相关;在为期240周的阿尔茨海默病药物索拉奈珠单抗治疗中,脑特征更年轻与更衰老的参与者表现出不同的认知下降轨迹,但该异质性不能完全归因于药物。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Biological aging clocks across organ systems and tissues have advanced understanding of human aging and disease. In this study, we expand this framework to develop seven magnetic resonance imaging-based multi-organ biological age gaps (MRIBAGs), including the brain, heart, liver, adipose tissue, spleen, kidney and pancreas. Using data from 313,645 individuals curated by the MULTI Consortium, we link the seven MRIBAGs to 2,923 plasma proteins, 327 metabolites and 6,477,810 common genetic variants. Genome-wide associations identify 53 MRIBAG-locus pairs (P < 5 × 10-8). Genetic correlation and Mendelian randomization analyses support organ-specific and cross-organ interconnection, including 24 non-MRI biological aging clocks and 525 disease endpoints. Through functional gene mapping and Bayesian co-localization multi-omics evidence, we prioritize nine druggable genes as targets for future anti-aging treatments. Furthermore, the seven MRIBAGs are linked to future risk of systemic disease endpoints (for example, diabetes mellitus) and all-cause mortality. Finally, participants with more youthful versus more aged brain profiles exhibited distinct cognitive decline trajectories over 240 weeks of treatment with the Alzheimer's disease drug solanezumab, although this heterogeneity cannot be fully attributed to the drug. In summary, we developed seven MRIBAGs that enhance the existing multi-organ biological aging framework, and we demonstrate their clinical potential to advance aging research.

来源:Nat Med,查看原文。版权归原作者所有。

引用

  1. Cao H, Song Z, Duggan MR, et al. MRI-based multi-organ clocks for healthy aging and disease assessment. Nat Med. 2025. PMID: 41102562. doi:10.1038/s41591-025-03999-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。